Emmanuel Ndashimye
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0002-9112-9402Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda”.
Mariano Avino, Abayomi S. Olabode, Art F. Y. Poon, Richard M. Gibson, Yue Li +9 more
Hannah O. Ajoge, Macon D. Coleman, Emmanuel Ndashimye, Richard M. Gibson, Eric J. Arts +2 more
J Pankrac, Emmanuel Ndashimye, Jessica L. Prodger, Melissa-Rose Abrahams, Jamie F. S. Mann +3 more
Yue Li, Paul S Reyes, Mariano Avino, Abayomi S. Olabode, Cissy Kityo +6 more
Paul S Reyes, Eric J. Arts, Emmanuel Ndashimye
Hannah O. Ajoge, Macon D. Coleman, Emmanuel Ndashimye, Richard M. Gibson, Eric J. Arts +2 more
J Pankrac, Ryan C. Y. Ho, Emmanuel Ndashimye, Rahul Pawa, Renata Ceccacci +21 more